Table: SymBio Pharmaceuticals -2022 parent results

SymBio Pharmaceuticals

09/02/2023 06:30

Feb 9 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             10.01           8.26                                 
                 (+21.2 pct)    (+176.4 pct)                             
  Operating          1.97           1.02                                 
                 (+94.1 pct)                                             
  Recurring          2.00           1.00                                 
                 (+99.9 pct)                                             
  Net                1.19           2.03                                 
                 (-41.6 pct)                                             
  EPS             30.37 yen       53.04 yen                              
  EPS Diluted     29.95 yen       52.32 yen                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T